Write in a clean editor, then format for The Lancet Regional Health - Europe in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
The Lancet Regional Health - Europe is a peer-reviewed journal published by Elsevier, covering SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, COVID-19 epidemiological studies.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, The Lancet Regional Health - Europe 12 (2023) 45–58.
Formats any DOI in The Lancet Regional Health - Europe style. No sign-up. |
| Publishes research in | SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies COVID-19 epidemiological studies Health Systems, Economic Evaluations, Quality of Life COVID-19 and healthcare impacts |
| ISSN | 2666-7762 |
| Citation impact (2-yr) | 8.3 |
| h-index | 88 |
| i10-index | 696 |
| Total citations | 36,347 |
| Article processing charge | $3,500 |
| Open access | Yes |
| Top institutions publishing here | Inserm |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
BACKGROUND: Negative attitudes towards vaccines and an uncertainty or unwillingness to receive vaccinations are major barriers to managing the COVID-19 pandemic in the long-term. We estimate predictors of four domains of negative attitudes towards vaccines and identify groups most at risk of uncertainty and unwillingness to receive a COVID-19 vaccine in a large sample of…
BACKGROUND: While the leading symptoms during coronavirus disease 2019 (COVID-19) are acute and the majority of patients fully recover, a significant fraction of patients now increasingly experience long-term health consequences. However, most data available focus on health-related events after severe infection and hospitalisation. We present a longitudinal, prospective analysis of health consequences in patients who…
SARS-CoV-2 mRNA vaccines have proven high efficacy, however, limited data exists on the duration of immune responses and their relation to age and side effects. We studied the antibody and memory T cell responses after the two-dose BNT162b2 vaccine in 122 volunteers up to 6 months and correlated the findings with age and side effects.…
Atrial fibrillation (AF) is highly prevalent with a lifetime risk of about 1 in 3-5 individuals after the age of 45 years. Between 2010 and 2019, the global prevalence of AF has risen markedly from 33.5 million to 59 million individuals living with AF. Early detection of AF and implementation of appropriate treatment could reduce…
Background: Mental health is a public health issue for European young people, with great heterogeneity in resource allocation. Representative population-based studies are needed. The Global Burden of Disease (GBD) Study 2019 provides internationally comparable information on trends in the health status of populations and changes in the leading causes of disease burden over time. Methods:…
